Obesity, metabolic syndrome, and airway disease: a bioenergetic problem?
- PMID: 25282291
- PMCID: PMC4482229
- DOI: 10.1016/j.iac.2014.07.004
Obesity, metabolic syndrome, and airway disease: a bioenergetic problem?
Abstract
Multiple studies have determined that obesity increases asthma risk or severity. Metabolic changes of obesity, such as diabetes or insulin resistance, are associated with asthma and poorer lung function. Insulin resistance is also found to increase asthma risk independent of body mass. Conversely, asthma is associated with abnormal glucose and lipid metabolism, insulin resistance, and obesity. Here we review our current understanding of how dietary and lifestyle factors lead to changes in mitochondrial metabolism and cellular bioenergetics, inducing various components of the cardiometabolic syndrome and airway disease.
Keywords: Arginine; Asthma; Bioenergetics; Metabolic syndrome; Metformin; Mitochondria; Reactive oxygen species; Statin.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
References
-
- Kent BD, Lane SJ. Twin epidemics: asthma and obesity. Int Arch Allergy Immunol. 2012;157:213–214. - PubMed
-
- Brisbon N, Plumb J, Brawer R, Paxman D. The asthma and obesity epidemics: the role played by the built environment--a public health perspective. J Allergy Clin Immunol. 2005;115:1024–1028. - PubMed
-
- Beuther DA. Recent insight into obesity and asthma. Curr Opin Pulm Med. 2010;16:64–70. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
